About Us
Jiuzhitang Maker
Jiuzhitang Co., Ltd. is a key national Chinese medicine enterprise, a national-level high-tech enterprise, a nationally recognized innovative pilot enterprise, the institution responsible for developing the key discipline of Traditional Chinese Medicine Engineering under the State Administration of Traditional Chinese Medicine, a National Enterprise Technology Center, a National Intellectual Property Demonstration Enterprise, a domestic A-share listed company, a benchmark demonstration enterprise for industrial quality in Hunan Province, a recipient of the inaugural Changsha Mayor’s Quality Award, and a National Postdoctoral Research Workstation.
The predecessor of Jiuzhitang, the "Lao Jiuzhitang Pharmacy," was founded in the seventh year of the Shunzhi reign of the Qing Dynasty—equivalent to 1650 AD. In 2000, Jiuzhitang was listed on the Shenzhen Stock Exchange under stock code 000989. In September 2006, "Jiuzhitang" was officially recognized as a "Time-Honored Brand of China" by China's Ministry of Commerce. Then, in June 2008, Jiuzhitang's traditional Chinese medicine culture was inscribed on the National List of Intangible Cultural Heritage for Protection.
For years, Jiuzhitang has steadfastly upheld the patriotic spirit of "Uniting the Nine Provinces, Sharing Prosperity Together; Cultivating Virtue Like Orchids and Fragrant Herbs," continuously innovating through tradition and thriving on innovation. Today, it has grown into a leading modern pharmaceutical enterprise with 20 subsidiaries, over 500 chain stores, and a comprehensive business model integrating production, sales, research & development, and health management. In the 2023 China Brand Value Evaluation Report released recently, Jiuzhitang ranked seventh among the "Time-Honored Chinese Brands," boasting a brand value of 10.803 billion yuan and a brand strength score of 871—marking a two-place improvement from the previous year.
The company boasts a diverse portfolio of products, including traditional Chinese medicines, premium herbal extracts, biopharmaceuticals, and innovative health solutions. At the heart of its growth strategy are flagship products such as Shuxuetong Injection, Donkey-Gelatin Blood-Nourishing Granules, Liuwei Dihuang Pills, E Jiao (donkey-hide gelatin), Angong Niuhuang Pills, Zuguang San, Bushen Guchi Wan, Luohua Zizhu Tablets, and Siquikang—each playing a pivotal role in driving the company forward. These product lines span across key therapeutic areas, including cardiovascular and cerebrovascular health, kidney tonification, blood enrichment, women’s and children’s health, and ENT care, providing comprehensive, lifecycle-focused support for public well-being. While firmly maintaining its core business, Jiuzhitang is actively expanding into a new model of chain medical clinics. Notably, the Jiuzhitang Health Building in Changsha has successfully been approved as one of the nation’s first batch of National Demonstration Bases for Traditional Chinese Medicine–Based Health Tourism, marking a significant milestone that underscores the company’s transition—from a pharmaceutical powerhouse to a cultural heritage leader deeply rooted in TCM traditions.
Jiuzhitang is committed to its mission of "Serving Greater Health for a Century," firmly embracing the development philosophy of "combining tradition with innovation." By integrating traditional medicine with precision medicine, the company is expanding into the fields of biopharmaceuticals and regenerative medicine. Jiuzhitang is dedicated to delivering precise and effective health management solutions across the entire human lifecycle—spanning prevention, treatment, and rehabilitation—and positioning the greater health sector as both the starting point and ultimate goal for the company's future growth. Through this vision, Jiuzhitang aims to strengthen its century-old brand while pioneering advancements in China’s national health industry.
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy